Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering Following Subarachnoid Block
NCT02441673Phase 2
Key facts
- Status
- Unknown
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Sponsor
- Lagos State Health Service Commission
- Modality
- Small Molecules
- Drugs
- nefopam
- Conditions
- postanesthetic shivering (PAS)
01
Overview
Phase 2, randomised, double-blind trial of nefopam in postanesthetic shivering (PAS) (2 arms), sponsored by Lagos State Health Service Commission. Primary endpoints: Presence of Post Anaesthetic Shivering at 60 months and Severity of Post Anaesthetic Shivering at 60 months. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Nefopam
Nefopam 0.15mg/kg IV
Tramadol
Tramadol 1mg/kg IV
03
Who it enrols
Female patients aged 18-45 with ASA physical status II or III scheduled for Caesarean Section amenable to Subarachnoid block.
04
Endpoints
Primary
Presence of Post Anaesthetic Shivering
Severity of Post Anaesthetic Shivering
Secondary
Presence of Vomiting and Retching
Change in Mean Arterial Pressure
Beyond the preview
Go deeper on NCT02441673.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441673.